At the PDA/FDA Conference, the FDA, Sanofi, and Gilead weighed AI readiness and validation risk.
Summaries like this, in your inbox every morning.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
OpenAI launched Astra for Law, wrapping GPT-6 Astra in a legal search index covering US case law, statutes, re…
Britain's royal household announced that King Charles hosted an AI summit at Dumfries House on September 17, d…
Nvidia CEO Jensen Huang rejected the notion that the industry must choose between safety and speed, saying "yo…
Novo Nordisk will partner with Anthropic to speed up drug development
The FAA will soon launch SMART — Strategic Management of Airspace, Routes, and Trajectories — an $875 million…
Morgan Stanley analyst Matthew Cost began covering Booking Holdings with an Overweight rating and a $230 price…
